RNA
#3602
Atrium Therapeutics, Inc. - Common Stock
12.2 2 USD
0.00%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
0.00%
Variación mensual
-4.16%
Variación en los últimos 6 meses
-83.17%
Cambio anual
-82.62%
Cierres anteriores
12.2 2
Open
12.2 2
Mínimo
12.2 2
High
12.2 2
Volumen
29
Financials
- Market Capitalization 209.03 M
- Employee 391
- Founded 2025
- CEO Troy Wilson
- Website www.aviditybiosciences.com
- Headquarter Delaware, United States
- FIGI BBG01Z0T3959
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3599 |  KROS Keros Therapeutics, Inc. - common stock | 10.50 USD | -0.66% | -10.03% | +2.44% | -30.46% | 207.81 M USD | ||
| 3601 |  OTLK Outlook Therapeutics, Inc. - Common Stock | 1.73 USD | 0.00% | +21.83% | +45.38% | +319.39% | 209.09 M USD | ||
| 3606 |  NBP NovaBridge Biosciences - American Depositary Shares | 1.84 USD | +2.22% | -5.64% | +14.29% | -59.20% | 212.30 M USD | ||
| 3609 |  CLLS Cellectis S.A. - American Depositary Shares | 2.88 USD | 0.00% | -8.86% | -8.57% | +46.19% | 206.64 M USD |